Cargando…
Identifying metabolite markers for preterm birth in cervicovaginal fluid by magnetic resonance spectroscopy
INTRODUCTION: Preterm birth (PTB) may be preceded by changes in the vaginal microflora and metabolite profiles. OBJECTIVES: We sought to characterise the metabolite profile of cervicovaginal fluid (CVF) of pregnant women by 1H NMR spectroscopy, and assess their predictive value for PTB. METHODS: A p...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783437/ https://www.ncbi.nlm.nih.gov/pubmed/27065760 http://dx.doi.org/10.1007/s11306-016-0985-x |
_version_ | 1782420107846221824 |
---|---|
author | Amabebe, Emmanuel Reynolds, Steven Stern, Victoria L. Parker, Jennifer L. Stafford, Graham P. Paley, Martyn N. Anumba, Dilly O. C. |
author_facet | Amabebe, Emmanuel Reynolds, Steven Stern, Victoria L. Parker, Jennifer L. Stafford, Graham P. Paley, Martyn N. Anumba, Dilly O. C. |
author_sort | Amabebe, Emmanuel |
collection | PubMed |
description | INTRODUCTION: Preterm birth (PTB) may be preceded by changes in the vaginal microflora and metabolite profiles. OBJECTIVES: We sought to characterise the metabolite profile of cervicovaginal fluid (CVF) of pregnant women by 1H NMR spectroscopy, and assess their predictive value for PTB. METHODS: A pair of high-vaginal swabs was obtained from pregnant women with no evidence of clinical infection and grouped as follows: asymptomatic low risk (ALR) women with no previous history of PTB, assessed at 20–22 gestational weeks, g.w., n = 83; asymptomatic high risk (AHR) women with a previous history of PTB, assessed at both 20–22 g.w., n = 71, and 26–28 g.w., n = 58; and women presenting with symptoms of preterm labor (PTL) (SYM), assessed at 24–36 g.w., n = 65. Vaginal secretions were dissolved in phosphate buffered saline and scanned with a 9.4 T NMR spectrometer. RESULTS: Six metabolites (lactate, alanine, acetate, glutamine/glutamate, succinate and glucose) were analysed. In all study cohorts vaginal pH correlated with lactate integral (r = −0.62, p < 0.0001). Lactate integrals were higher in the term ALR compared to the AHR (20–22 g.w.) women (p = 0.003). Acetate integrals were higher in the preterm versus term women for the AHR (20–22 g.w.) (p = 0.048) and SYM (p = 0.003) groups; and was predictive of PTB < 37 g.w. (AUC 0.78; 95 % CI 0.61–0.95), and delivery within 2 weeks of the index assessment (AUC 0.84; 95 % CI 0.64–1) in the SYM women, whilst other metabolites were not. CONCLUSION: High CVF acetate integral of women with symptoms of PTL appears predictive of preterm delivery, as well as delivery within 2 weeks of presentation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11306-016-0985-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4783437 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-47834372016-04-06 Identifying metabolite markers for preterm birth in cervicovaginal fluid by magnetic resonance spectroscopy Amabebe, Emmanuel Reynolds, Steven Stern, Victoria L. Parker, Jennifer L. Stafford, Graham P. Paley, Martyn N. Anumba, Dilly O. C. Metabolomics Original Article INTRODUCTION: Preterm birth (PTB) may be preceded by changes in the vaginal microflora and metabolite profiles. OBJECTIVES: We sought to characterise the metabolite profile of cervicovaginal fluid (CVF) of pregnant women by 1H NMR spectroscopy, and assess their predictive value for PTB. METHODS: A pair of high-vaginal swabs was obtained from pregnant women with no evidence of clinical infection and grouped as follows: asymptomatic low risk (ALR) women with no previous history of PTB, assessed at 20–22 gestational weeks, g.w., n = 83; asymptomatic high risk (AHR) women with a previous history of PTB, assessed at both 20–22 g.w., n = 71, and 26–28 g.w., n = 58; and women presenting with symptoms of preterm labor (PTL) (SYM), assessed at 24–36 g.w., n = 65. Vaginal secretions were dissolved in phosphate buffered saline and scanned with a 9.4 T NMR spectrometer. RESULTS: Six metabolites (lactate, alanine, acetate, glutamine/glutamate, succinate and glucose) were analysed. In all study cohorts vaginal pH correlated with lactate integral (r = −0.62, p < 0.0001). Lactate integrals were higher in the term ALR compared to the AHR (20–22 g.w.) women (p = 0.003). Acetate integrals were higher in the preterm versus term women for the AHR (20–22 g.w.) (p = 0.048) and SYM (p = 0.003) groups; and was predictive of PTB < 37 g.w. (AUC 0.78; 95 % CI 0.61–0.95), and delivery within 2 weeks of the index assessment (AUC 0.84; 95 % CI 0.64–1) in the SYM women, whilst other metabolites were not. CONCLUSION: High CVF acetate integral of women with symptoms of PTL appears predictive of preterm delivery, as well as delivery within 2 weeks of presentation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11306-016-0985-x) contains supplementary material, which is available to authorized users. Springer US 2016-03-08 2016 /pmc/articles/PMC4783437/ /pubmed/27065760 http://dx.doi.org/10.1007/s11306-016-0985-x Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Amabebe, Emmanuel Reynolds, Steven Stern, Victoria L. Parker, Jennifer L. Stafford, Graham P. Paley, Martyn N. Anumba, Dilly O. C. Identifying metabolite markers for preterm birth in cervicovaginal fluid by magnetic resonance spectroscopy |
title | Identifying metabolite markers for preterm birth in cervicovaginal fluid by magnetic resonance spectroscopy |
title_full | Identifying metabolite markers for preterm birth in cervicovaginal fluid by magnetic resonance spectroscopy |
title_fullStr | Identifying metabolite markers for preterm birth in cervicovaginal fluid by magnetic resonance spectroscopy |
title_full_unstemmed | Identifying metabolite markers for preterm birth in cervicovaginal fluid by magnetic resonance spectroscopy |
title_short | Identifying metabolite markers for preterm birth in cervicovaginal fluid by magnetic resonance spectroscopy |
title_sort | identifying metabolite markers for preterm birth in cervicovaginal fluid by magnetic resonance spectroscopy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783437/ https://www.ncbi.nlm.nih.gov/pubmed/27065760 http://dx.doi.org/10.1007/s11306-016-0985-x |
work_keys_str_mv | AT amabebeemmanuel identifyingmetabolitemarkersforpretermbirthincervicovaginalfluidbymagneticresonancespectroscopy AT reynoldssteven identifyingmetabolitemarkersforpretermbirthincervicovaginalfluidbymagneticresonancespectroscopy AT sternvictorial identifyingmetabolitemarkersforpretermbirthincervicovaginalfluidbymagneticresonancespectroscopy AT parkerjenniferl identifyingmetabolitemarkersforpretermbirthincervicovaginalfluidbymagneticresonancespectroscopy AT staffordgrahamp identifyingmetabolitemarkersforpretermbirthincervicovaginalfluidbymagneticresonancespectroscopy AT paleymartynn identifyingmetabolitemarkersforpretermbirthincervicovaginalfluidbymagneticresonancespectroscopy AT anumbadillyoc identifyingmetabolitemarkersforpretermbirthincervicovaginalfluidbymagneticresonancespectroscopy |